Home » Newsletters » BioWorld Science

BioWorld Science

July 20, 2001

View Archived Issues

New erectile dysfunction therapy now available in U.K.

Mechanism of action of Mylotarg in AML elucidated

Millennium continues momentum during Q2 2001

Decitabine holds potential for chemotherapy of resistant ovarian and colon cancer

Vertex completes acquisition of Aurora Biosciences

F-13714: a high-efficacy 5-HT1A receptor agonist with potent antidepressant-like effects

Profile of a third-generation dihydropyridine-type calcium channel blocker

Tracleer NDA to be reviewed by FDA advisory committee next month

Hybrid compounds designed to have enhanced minor groove binding and cytotoxic activity

First launch for diclofenac gel formulation for actinic keratoses

Arius Research begins preparations for phase I clinical trials of cancer-killing antibodies

Rapid and effective control of malignancy-associated hyperuricemia achieved on rasburicase

University of Pittsburgh awarded two grants to support AIDS research

EMEA assigns orphan drug status to gene therapy for SCID-X1

Neurochem and Nycomed Amersham Imaging to develop Alzheimer's diagnostic

Y-27632 inhibits noradrenergic contractions in penile tissue

Novartis acquires certain rights to investigational diabetes drug from Novo Nordisk

Oxxon Pharmaccines licenses adenovirus vaccine technology from Isis Innovation

Discovery Partners and Maxia extend drug discovery collaboration

Gel formulations of anionic surfactants useful against sexually transmitted pathogens

MorphoSys reaches milestone in antibody collaboration with GPC Biotech

MetaPhore's M-40403 successfully completes phase I evaluation

Webcast introducing Prous Science Integrity, the first integrated drug discovery portal

Pfizer focuses significant effort on the search for selective COX-2 inhibitors

Naturally occurring estrogen-like agonist discovered by Nippon Kayaku

NPY Y5 ligands have favorable effects on eating

Hypoglycemic/hypolipidemic compounds in development at Takeda

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...